PROCEPT BioRobotics Corp (PRCT)
68.16
+0.02
(+0.03%)
USD |
NASDAQ |
May 17, 16:00
65.00
-3.16
(-4.64%)
After-Hours: 20:00
PROCEPT BioRobotics SG&A Expense (Quarterly): 39.60M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 39.60M |
December 31, 2023 | 36.32M |
September 30, 2023 | 32.88M |
June 30, 2023 | 32.44M |
March 31, 2023 | 30.13M |
December 31, 2022 | 26.03M |
September 30, 2022 | 24.75M |
June 30, 2022 | 19.66M |
Date | Value |
---|---|
March 31, 2022 | 18.38M |
December 31, 2021 | 16.27M |
September 30, 2021 | 12.12M |
June 30, 2021 | 12.30M |
March 31, 2021 | 10.35M |
December 31, 2020 | 9.134M |
September 30, 2020 | 7.054M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
7.054M
Minimum
Sep 2020
39.60M
Maximum
Mar 2024
21.83M
Average
19.66M
Median
Jun 2022
SG&A Expense (Quarterly) Benchmarks
Intuitive Surgical Inc | 491.50M |
Integra Lifesciences Holdings Corp | 165.80M |
Masimo Corp | 159.90M |
Perspective Therapeutics Inc | 5.878M |
Xtant Medical Holdings Inc | 20.24M |